Sat.Aug 03, 2024 - Fri.Aug 09, 2024

article thumbnail

Use Your Voice: Pharmacists as Patient Advocates

Drug Topics

From expanding vaccination coverage to battling with PBMs, the community pharmacist has the ability to promote change like never before.

Vaccines 529
article thumbnail

Pharma execs react to final drug price negotiations with Medicare

PharmaVoice

Here’s what the leaders of the companies with the 10 drugs in the first wave of price negotiations with Medicare said about how the new prices will impact their portfolio.

228
228
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves First Nasal Spray for Anaphylaxis

Pharmacy Times

neffy is an epinephrine nasal spray for the emergency treatment of allergic reactions in adults and pediatric patients.

FDA 160
article thumbnail

Opinion: Noah Lyles’ collapse with Covid: How not to manage health at the Olympics

STAT

Noah Lyles, a 27-year-old from Gainesville, Florida, has had himself quite an Olympics. He won a gold medal in a photo finish in the 100-meter dash on August 4. He went on to win a bronze medal in the 200-meter dash four days later, then collapsed in a heap and needed a wheelchair to get off the track, suggesting that sports officials and team doctors have put athletes’ health last, not first, during the Paris Olympics.

145
145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Student, Staffing Shortages Continue to Impact Pharmacy Profession

Drug Topics

The COVID-19 pandemic led to increased pharmacist burnout and workforce shortages. The impact is still being felt today.

548
548
article thumbnail

Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half

PharmaVoice

The top drugs at each of the world’s most valuable pharma companies tell the story of just how much the industry has changed over the course of a few years.

162
162

More Trending

article thumbnail

CDC slightly increases risk bird flu could cause a pandemic in latest assessment

STAT

The Centers for Disease Control and Prevention issued a new risk assessment of the H5N1 bird flu virus circulating in dairy cows on Friday, increasing slightly its estimate of the chance it poses of triggering a pandemic. The new assessment , developed using the CDC’s influenza risk assessment tool or IRAT, gauged the risk the virus might someday cause a pandemic at 5.79, up from a previous score of 5.12 from an assessment of a related virus conducted in April 2023.

145
145
article thumbnail

Healthful Diets Are Crucial, But Population-Level Follow-Through Remains a Challenge

Drug Topics

Health care professionals all agree that a healthy diet is the foundation of cardiovascular and cardiometabolic health, but follow-through on the population level is lacking.

527
527
article thumbnail

Pfizer, GSK and Moderna execs remain optimistic about RSV vaccines despite CDC blowback

PharmaVoice

An advisory committee’s age group recommendations look like a major setback, but executives are painting a rosier picture.

Vaccines 147
article thumbnail

Report: Satisfaction of Mail-Order Pharmacies Rise, Decreases for Community Pharmacies

Pharmacy Times

Customers report that their communication is strong with their pharmacists, but only 51% said their pharmacist was trustworthy.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

FDA approves EpiPen alternative, a nasal spray for anaphylaxis

STAT

On Friday, the Food and Drug Administration approved the first needle-free treatment for adults and kids with severe allergic reactions. The approval introduces a competitor from ARS Pharma to older epinephrine products, like the EpiPen. Neffy, as the product is called, is a nasal spray that delivers the same drug used to treat anaphylaxis. It is ARS’ flagship product.

FDA 145
article thumbnail

Cannabis Use Associated with Increased Risk of Head and Neck Cancer

Drug Topics

A cohort study was conducted to address the association between patients with cannabis-related disorders and their risk of developing head and neck cancer.

503
503
article thumbnail

In a Duchenne market beset by problems, Capricor data marks a bright spot

PharmaVoice

The company’s cell therapy recently showed positive results from a mid-stage trial.

147
147
article thumbnail

Expert: Psychosis in Alzheimer Disease Contributes to Rapid Cognitive, Functional Decline

Pharmacy Times

In addition to a rapid deterioration, psychosis in Alzheimer disease can also lead to poorer quality of life, damaging patients’ relationships with caregivers, and increases isolation.

149
149
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

FDA rejects MDMA as a psychedelic treatment for PTSD

STAT

The Food and Drug Administration rejected MDMA as a treatment for post-traumatic stress disorder on Friday, in a blow to drug activists and veterans who’ve long campaigned for the psychedelic treatment. Although two Phase 3 trials suggested the treatment was effective, strong opposition by an agency scientific advisory committee in June and allegations of missing adverse event data and research bias may have doomed the application by Lykos Therapeutics.

FDA 145
article thumbnail

The 2024-2025 Flu Season: What to Expect

Drug Topics

The composition of the latest flu vaccine has changed. Here’s what pharmacists need to know.

Vaccines 502
article thumbnail

Epic rolls out new feature to make it easier for patients to share medical records with health apps

Fierce Healthcare

Medical records software giant Epic has rolled out a new feature that makes it easier for patients to release their medical records to the health or wellness apps they use. | The new capability is part of a wider effort by the healthcare industry, facilitated by new health tech policies from the federal government, to advance data-sharing at scale.

article thumbnail

New Evidence Supports Cholesterol Absorption Inhibitors in Liver Cancer Prevention

Pharmacy Times

Statins and non-statin cholesterol-lowering agents show potential in reducing the risk of liver cancer.

145
145
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Scientists are starting to uncover how neighborhood can affect the biology of cancer

STAT

Where you live has a relationship to your odds of getting cancer and surviving cancer. Epidemiologists studying this link they see in the data have focused on so-called social determinants of health — poor access to transportation, for example, could make it harder for residents to see a doctor. Places lacking grocery stores with fresh food could mean worse nutrition for locals.

article thumbnail

Problematic Opioid Prescribing Among Patients with Chronic Pain

Drug Topics

Researchers conducted a systematic review of literature exploring the misuse of opioid prescriptions for patients with chronic non-cancer pain.

503
503
article thumbnail

Appeals court upholds ruling that struck down surprise billing arbitration process

Fierce Healthcare

A federal appeals court has upheld a lower court decision that struck down key parts of legislation aimed at reforming surprise medical billing. | A federal appeals court upheld a lower court decision that struck down key parts of legislation aimed at reforming surprise medical billing.

141
141
article thumbnail

GLP-1 Agonists Show Promise in Treatment of Neurodegenerative Disorders

Pharmacy Times

Significant commonalities between type 2 diabetes and neurodegenerative disorders suggest that treatments effective for one condition may benefit the other.

145
145
article thumbnail

As Covid deaths drop, heart disease and cancer remain leading causes of death

STAT

Since its emergence in 2020, Covid has jumbled the list of the 10 leading causes of deaths in the United States. It roared into third place in 2020 but has now fallen to 10th place, the National Center for Health Statistics reported Thursday.  Heart disease and cancer remained the first and second leading causes of death, followed by unintentional injuries as No. 3.

145
145
article thumbnail

New Report Scrutinizes PBM Spread Pricing Practice

Drug Topics

Findings from the study conducted by 3 Axis Advisors confirm that PBM practices have an impact on pharmacies.

501
501
article thumbnail

ASTP/ONC proposal would require HHS contractors to use certified health IT tech

Fierce Healthcare

The Department of Health and Human Services’ technology office dropped a new proposed rule on Thursday that would require healthcare entities that contract with HHS to use government-cert | The newly rebranded Office of the Assistant Secretary of Technology Policy released a proposed rule Thursday that could expand the use of government-certified health technology.

136
136
article thumbnail

Study Finds Abacavir Increases Cardiovascular Risk in Patients With HIV

Pharmacy Times

Cholesterol-lowering agents, like statins, reduced the risk of major adverse cardiovascular events and cardiovascular disease in patients with HIV.

144
144
article thumbnail

STAT+: How UnitedHealth turned a questionable artery-screening program into a gold mine

STAT

The nation’s largest health care company pressed thousands of its clinicians to use a thinly tested medical device to screen people for artery disease, dramatically boosting payments from the federal government for years even though many of the patients were not sick, a STAT investigation found. The result was a torrent of sometimes questionable diagnoses of peripheral artery disease.

Insurance 145
article thumbnail

Weekend ICYMI: July 29 to August 2

Drug Topics

In case you missed it, this week we had news about CVS in the spotlight of PBM reform, landmark FDA approvals in synovial sarcoma, liraglutide for dementia, and more.

FDA 467
article thumbnail

BioNTech posts €808M loss as company continues to come to grips with seasonal COVID vaccine market

Fierce Pharma

While Pfizer’s German mRNA partner BioNTech has high hopes for its post-COVID future, the company continues to feel the squeeze from the changeover to a seasonal vaccine market. | While Pfizer’s German mRNA partner BioNTech has high hopes for its post-COVID future, the company continues to feel the squeeze from the changeover to a seasonal vaccine market.

Vaccines 136
article thumbnail

Developing Relationships With State Boards of Pharmacy Is Valuable for Pharmacies and Pharmacists

Pharmacy Times

A pharmacy's relationship with its state board(s) of pharmacy is crucial for its operation and success, yet it is often overlooked due to the complex demands on pharmacists and pharmacy owners.

144
144
article thumbnail

Opinion: Diversity statements should not be required for federal STEMM grant funding

STAT

Federally funded research in science, technology, engineering, mathematics, and medicine (STEMM) is a crown jewel of American higher education that confers enormous benefits upon the U.S. and the world. The integrity of the processes by which funding decisions are made is critically important to the success of the enterprise and its support by the public who pay for this research.

article thumbnail

Online Pharmacies Are Illegally Selling GLP-1s Without Prescriptions

Drug Topics

A study found that test products purchased from illegal online pharmacy operations had lower purity levels and significantly more semaglutide content than what was advertised on the label.

Labelling 407
article thumbnail

FDA releases roster of digital health advisory committee, chaired by American College of Cardiology innovation officer

Fierce Healthcare

FDA releases roster of digital health advisory committee, chaired by American College of Cardiology innovation officer ebeavins Tue, 08/06/2024 - 10:26

FDA 133